NeoGenomics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NeoGenomics, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $189.86M, a 49.15% increase year-over-year.
- NeoGenomics, Inc. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $218.50M.
- NeoGenomics, Inc. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $127.29M, a 20.82% decline year-over-year.
- NeoGenomics, Inc. stock issued during period, value, new issues for the quarter ending 2019-06-30 was $160.77M.
- NeoGenomics, Inc. stock issued during period, value, new issues for fiscal 2021 was $218.50M, a 71.65% increase from fiscal 2020.
- NeoGenomics, Inc. stock issued during period, value, new issues for fiscal 2020 was $127.29M, a 20.82% decline from fiscal 2019.
- NeoGenomics, Inc. stock issued during period, value, new issues for fiscal 2019 was $160.77M, a 19.03% increase from fiscal 2018.
- NeoGenomics, Inc. stock issued during period, value, new issues for fiscal 2018 was $135.07M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-12-31 | $218.50M 10-K · filed 2024-02-20 | |
| 2021-06-30 | $189.86M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $218.50M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $127.29M 10-K · filed 2023-02-24 | |
| 2020-06-30 | $127.29M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $160.77M 10-K · filed 2022-02-25 | |
| 2019-06-30 | $160.77M 10-Q · filed 2020-10-29 | |
| 2018-12-31 | $135.07M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $135.07M 10-Q · filed 2019-11-13 | |
| 2014-12-31 | $37.03M 10-K · filed 2017-03-14 | |
| 2013-12-31 | $768.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-18 | $9.97M 10-K · filed 2016-04-18 |
| 2013-06-30 | $9.20M 10-Q · filed 2013-08-02 | |
| 2011-12-31 | $3.00M 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |